SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?

被引：1
|
作者：
Theodorakopoulou, Marieta P. [1 ]
Sarafidis, Pantelis [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Nephrol 1, Thessaloniki, Greece
来源：
CLINICAL KIDNEY JOURNAL | 2024年 / 17卷 / 01期
关键词：
CHRONIC KIDNEY-DISEASE;
D O I：
10.1093/ckj/sfad272
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal disease
    Perico, Norberto
    Ruggenenti, Piero
    Remuzzi, Giuseppe
    CURRENT OPINION IN PHARMACOLOGY, 2017, 33 : 34 - 40
  • [2] SGLT2 inhibitors in non-diabetic kidney disease
    Tesar, Vladimir
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (02): : 105 - 107
  • [3] SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
    Podesta, Manuel Alfredo
    Sabiu, Gianmarco
    Galassi, Andrea
    Ciceri, Paola
    Cozzolino, Mario
    BIOMEDICINES, 2023, 11 (02)
  • [4] SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
    Fernandez-Fernandez, Beatriz
    Sarafidis, Pantelis
    Kanbay, Mehmet
    Navarro-Gonzalez, Juan F.
    Jose Soler, Maria
    Luis Gorriz, Jose
    Ortiz, Alberto
    CLINICAL KIDNEY JOURNAL, 2020, 13 (05) : 728 - 733
  • [5] SGLT2 inhibition in non-diabetic CKD: results in experimental lupus nephritis
    Jacobs Cacha, Conxita
    Martos, Nerea
    Llorens Cebria, Carmen
    Motto, Enam
    Martinez-Diaz, Irene
    Anders, Hans Joachim
    Soler Romeo, Maria Jose
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1222 - I1222
  • [6] SGLT2 inhibition in non-diabetic CKD: results in experimental lupus nephritis
    Cacha, Conxita Jacobs
    Martos, Nerea
    Cebria, Carmen Llorens
    Motto, Enam
    Martinez-Diaz, Irene
    Anders, Hans Joachim
    Romeo, Maria Jose Soler
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [7] SGLT2 Inhibitors Reduce Urinary Mitochondrial DNA Copy Number in Both Diabetic and Non-Diabetic CKD Patients
    Lee, Haekyung
    Cho, Junghyun
    Chung, Eui Suk
    Kim, Hyoungnae
    Jeon, Jin Seok
    Kwon, Soon Hyo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 880 - 880
  • [8] SERENDIPITY OF SGLT2 INHIBITION - DIABETIC AND NON DIABETIC CKD
    Godanci-Kelmendi, Vjollca
    Piraj, Mimoza Ramadani
    Ymeri, Fatime
    Konjufca, Shega
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1182 - I1183
  • [9] SGLT2 inhibitors in diabetes with CKD
    Malik, A. H.
    Yandrapalli, S.
    Goldberg, M.
    Jain, D.
    Frishman, W. H.
    Aronow, W. S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1448 - 1448
  • [10] SGLT2 inhibitors and finerenone: one or the other or both?
    Neuen, Brendon L.
    Jardine, Meg J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (07) : 1209 - 1211
12345